Search

everythinglearnresearchcommunity

for

Search:↓

Quick, selective detection of tadalafil and finasteride in human plasma developed.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The article on the stomach-protecting effects of Cibotium barometz hair was retracted due to unreliable data.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Ascorbyl Tetraisopalmitate penetrates skin better in the stratum corneum than in the infundibulum.

Fermentation of Finasteride with Ocimum sanctum L. creates new metabolite that inhibits tyrosinase.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Activating β-catenin increases melanocytes and decreases Schwann cells.

Adipose tissue changes in obesity can trigger stress in fat cells.

New molecules can prevent cell death in hair follicles.

The topical solution increased hair count but wasn't significantly better than placebo in other measures.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Clobetasol nanocarriers can be effectively delivered to hair follicles, with uptake improved by massage and affected by particle type.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Christia vespertilionis extract may help fight breast cancer cells.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

CRH causes hair loss by reducing cell survival in hair follicles.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.